Nancy A. Dreyer, PhD, FISPE

Chief Scientific Officer

Nancy Dreyer is Senior Vice President and Chief Scientific Officer for Real World Solutions at IQVIA, and Adjunct Professor of Epidemiology at the University of North Carolina at Chapel Hill. At IQVIA Dreyer leads the Center for Advanced Evidence Generation, working to raise attention to the use of real world research to enhance and accelerate evidence generation. Her current work is focused on COVID-19 as well as other issues of regulatory and public health importance. Dreyer received the Red Jacket honor from PharmaVOICE in 2020 and DIA’s Global Inspire Award for Author of the Year in 2019

Presentation(s):

• L-1D - Patients Tell All: Using a Direct-to-patient Community Registry to Understand Patient Burden of COVID-19

  Monday, August 23, 2021
  5:30 PM – 6:30 PM US Eastern Time

• L-2B - Collider Bias in COVID-19 Studies: Explaining the Smoking Paradox

  Monday, August 23, 2021
  6:30 PM – 7:30 PM US Eastern Time

• WS-06 - From the Individual Through the Health System and Back: The Interdisciplinary Promise and Challenges of Digital Epidemiology for Improved Outcomes (An ISPE Digital Epidemiology SIG Endorsed Symposium)

  Tuesday, August 24, 2021
  10:00 AM – 11:30 AM US Eastern Time

• SP08C - Comparing Two Geographic Sources of Patient Generated Health Data (PGHD) in a COVID-19 Registry (CARE): UK and US Symptomatology

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time

• SP14G - Women of Reproductive Age in the COVID-19 Active Research Experience (CARE) Registry

  Tuesday, August 24, 2021
  5:15 PM – 6:30 PM US Eastern Time

• OP-5D - Persistence of COVID-19 Symptoms 90 Days Post-acute Infection: Insights from a Community-based Registry

  Wednesday, August 25, 2021
  11:45 AM – 1:30 PM US Eastern Time